Proteins and Peptides
20 September 2016
BioLineRx Announces Initiation of Phase 2a Trial of BL-8040 in Combination With KEYTRUDA® (pembrolizumab) for Treatment of Pancreatic Cancer19 September 2016
Stealth BioTherapeutics Reports Elamipretide Improved Skeletal Muscle Bioenergetics in the Elderly17 September 2016
Phase III Combination Trial of BYDUREON and FARXIGA Shows Significant Blood Sugar Reduction in Patients with Type 2 Diabetes16 September 2016
Semaglutide reduced major cardiovascular events by 26% in adults with type 2 diabetes at high cardiovascular risk14 September 2016
Inotrem Successfully Completes Its First Phase I Clinical Trial with Motrem™, a TREM-1 Pathway Modulator for the Treatment of Septic Shock13 September 2016
Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone13 September 2016
Semaglutide Demonstrated Superior HbA1c Reduction vs Placebo as Add-on to Basal Insulin Alone or with Metformin in Adults with type 2 Diabetes13 September 2016
Stealth BioTherapeutics Initiates Phase 2 Study of Elamipretide in Primary Mitochondrial Disease13 September 2016
Alizé Pharma III presents preclinical results from its I-HBD1 program at the Annual Meeting of the American Society for Bone and Mineral Research8 September 2016
La Jolla Pharmaceutical Company Reports Positive Results from Phase 1 Study of LJPC-4017 September 2016
BioMarin Announces Update to Brineura™ (Cerliponase Alfa) Program for Treatment of CLN2 Disease, a Form of Batten Disease1 September 2016
Long Acting Growth Hormone Based on Amunix’ XTEN(R) Technology Completes Enrollment of Phase 3 Trial30 August 2016
Aeglea BioTherapeutics Doses First Patient in Phase 1 Trial of AEB1102 for the Treatment of Hematological Malignancies29 August 2016
ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia27 August 2016
Adocia Announces Topline Results of Indian Phase 3 Trial of BioChaperone PDGF for Diabetic Foot Ulcer23 August 2016
Hansa Medical: Top line results from the Swedish ongoing Phase II study with IdeS in sensitized patients presented22 August 2016
Versartis Announces Completion of Enrollment in Phase 3 VELOCITY Trial of Somavaratan in Pediatric GHD18 August 2016
JAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With Osteoporosis18 August 2016
CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix™STR for Treatment of TendinopathyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports